Novavax incurred a third-quarter 2024 loss of 76 cents per share, narrower than the Zacks Consensus Estimate of a loss of 87 cents. In the year-ago quarter, the company reported a loss of $1.26 per ...
The earnings season is in its final week; giants of nifty and sensex have already posted their Q2 results. Today, their 1181 ...
Secures $3.2m in PIPE Financing -- $50m Term Sheet Obtained for Available Financing under Equity Line of Credit -BOSTON and LONDON, Nov. 14, ...
According to a recent article in Biospace ,"The solid tumors market size reached a value of US$ 170.3 Billion in 2023. Looking forward, the market is expected to reach US$ 375.4 Billion by 2034, ...
Citigroupa expanded its biotech coverage on Wednesday, adding five more stocks to the roster including Amgen (NASDAQ:AMGN), ...
Mizuho reiterated its bullish stance on biotech Neumora Therapeutics Inc. on Wednesday, and predicted a positive outcome when the company reports data from a late-stage trial of its treatment for ...
US stock market experienced a downward trend on Thursday, with both the Nasdaq Composite and the S&P 500 indices falling by ...
Which healthcare stock can dividend investors safely buy? Let's consider two excellent options: AbbVie ( ABBV -0.75%) and Amgen ( AMGN -2.82%).
There are two numbers to look for when getting a feel for market sentiment. Is the number of stocks trading above their daily 200sma on the increase? You want to know what’s changed in the past ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback